Showing results (101-110 of 197) with videos related to
Sort By:
Pageof 20
Journal of Pharmacological and Toxicological Methods|August 7, 1998
Polarographic detection of nitric oxide released from cardiovascular compounds in aqueous solutionsJ Pataricza, B Penke, G E Balogh, et al.European Journal of Pharmacology|June 5, 1997
Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmiasK Kaszala, A Végh, J G Papp, et al.British Journal of Pharmacology|September 1, 1993
Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogsA Vegh, J G Papp, L Szekeres, et al.Journal of Molecular and Cellular Cardiology|June 18, 1999
Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: role of nitric oxideA Kis, A Végh, J G Papp, et al.Dalton Transactions (Cambridge, England : 2003)|June 7, 2016
Highly efficient dehydrogenation of formic acid in aqueous solution catalysed by an easily available water-soluble iridium(iii) dihydrideG Papp, G Ölveti, H Horváth, et al.General Pharmacology|September 7, 2000
Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine isolated ventricular muscle and purkinje fibersB Baláti, N Iost, J Simon, et al.General Pharmacology|April 1, 1996
Cardiac electrophysiological effects of levosimendan, a new calcium sensitizerL Virág, O Hála, A Marton, et al.Cardiovascular Drugs and Therapy|December 2, 2000
Atrial natriuretic peptide reduces the severe consequences of coronary artery occlusion in anaesthetized dogsM A Rastegar, A Végh, J G Papp, et al.Pacing and Clinical Electrophysiology : PACE|February 25, 1998
Suppression of erythromycin-induced early afterdepolarizations and torsade de pointes ventricular tachycardia by mexiletineT Fazekas, I Krassói, C Lengyel, et al.The Journal of Pharmacy and Pharmacology|March 14, 2000
Comparison of the vasorelaxing effect of cromakalim and the new inodilator, levosimendan, in human isolated portal veinJ Pataricza, J Hõhn, A Petri, et al.Pageof 20